Enjaymo Marks Latest Milestone In Sanofi’s Blood Disorder Effort

3-D Rendering Red Blood Cells
Sanofi won approval for Enjaymo in cold agglutinin disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip